Most contemporary research on psychedelic drugs focuses on the treatment of psychological disorders such as depression and PTSD. Now, researchers at LSU Health New Orleans School of Medicine are investigating the use of the psychedelic (R)-DOI to treat asthma, a disease that affects 25 million...
News
The New Yorker magazine has a brief but powerful documentary video illustrating their recent article on psychedelic research. The video features cinematographer Eddie Marritz, one of the subjects in the Heffter-sponsored study on psilocybin therapy for cancer patients at New York University.Magic Mushrooms and the...
Addiction, News / 17.02.2015
MATTHEW JOHNSON: “PSYCHEDELIC THERAPY MAY BECOME AVAILABLE IN A DECADE”
In an interview on the website of the Open Foundation, Heffter researcher Matthew Johnson discusses many topics in the field of psychedelic science. Dr. Johnson talks with writer Olivier Taymans about his study on psilocybin as a treatment for tobacco addiction, the timeline for legalization...
An opinion piece in the popular news magazine THE WEEK encourages government funding of scientific research into psychedelics. National correspondent Brian Cooper examines how pharmaceutical companies fund research on new drugs using two examples–psychedelics and antibiotics. In both cases, the industry has financial incentives for avoiding research. The...
Cancer Distress, News / 02.02.2015
THE TRIP TREATMENT | THE NEW YORKER
As a sign of growing public awareness and acceptance of psychedelic research, The New Yorker, possibly the nation’s most prestigious general-interest magazine, features an extensive article on the subject in its issue of February 9th, 2015. Author Michael Pollan (The Omnivore’s Dilemma) focuses on the...
The study at the University of Alabama on psychedelics and suicide, cited in the previous post, is getting a lot of attention in the media. Newsweek covered the story in their issue of January 25, 2015. “A new study conducted by the University of Alabama at Birmingham...
The new issue of the journal Current Drug Abuse Reviews is devoted to psychedelic research. The issue includes articles on the use of psychedelics for treating substance abuse, crisis intervention, and the subjective experiences of psilocybin users in an fMRI study.“We are witnessing a revival of...
News / 23.01.2015
CLASSIC PSYCHEDELIC USE PROTECTIVE WITH REGARD TO PSYCHOLOGICAL DISTRESS AND SUICIDALITY | SCIENCEDAILY
Heffter-supported researchers at the University of Alabama and Johns Hopkins examined health data for 190,000 individuals and found that people who have used one of the classic psychedelic drugs are less prone to suicidal thoughts and actions.“Despite advances in mental health treatments, suicide rates generally...
Addiction, News / 14.01.2015
PSILOCYBIN-ASSISTED TREATMENT FOR ALCOHOL DEPENDENCE | JOURNAL OF PSYCHOPHARMACOLOGY
An important new research study at the University of New Mexico confirms that psilocybin is a promising treatment for heavy drinkers. Heffter researcher Michael Bogenschutz and his colleagues studied 10 individuals who were alcohol dependent for an average of 15.1 years.“Abstinence did not increase significantly...
News / 16.12.2014
HEFFTER NEWSLETTER – LIGHT AT THE END OF THE TUNNEL!
Light at the End of the Tunnel! Fall, 2014 Newsletter Dear Heffter Friends and Supporters: Why did I put that title at the top of this newsletter? Because after so many years of hard work, we now can actually see the final steps coming closer in our process...